HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Suo Selected Research

Chemotactic Factors

10/2012Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Suo Research Topics

Disease

8Inflammation (Inflammations)
10/2022 - 10/2012
5Pain (Aches)
11/2016 - 01/2013
4Hyperalgesia
01/2017 - 01/2013
3Neuralgia (Stump Neuralgia)
11/2016 - 03/2014
2Infections
01/2018 - 07/2015
2Hypersensitivity (Allergy)
11/2016 - 01/2015
1Adenocarcinoma of Lung
01/2021
1Vomiting
08/2019
1Acute Liver Failure (Fulminant Hepatic Failure)
08/2019
1Jaundice (Icterus)
08/2019
1Nausea
08/2019
1Tuberculosis (Tuberculoses)
05/2019
1Necrosis
01/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2018
1Esophageal Squamous Cell Carcinoma
01/2016
1Neoplasms (Cancer)
01/2016
1Virus Diseases (Viral Diseases)
07/2015
1Atherosclerosis
07/2015
1Wounds and Injuries (Trauma)
06/2015
1Edema (Dropsy)
07/2014

Drug/Important Bio-Agent (IBA)

5ZymosanIBA
01/2018 - 10/2012
4CytokinesIBA
10/2022 - 01/2016
4LipidsIBA
01/2017 - 01/2013
3InterleukinsIBA
10/2022 - 03/2014
2Interleukin-6 (Interleukin 6)IBA
10/2022 - 01/2019
2Interleukin-10 (Interleukin 10)IBA
10/2022 - 01/2019
2Ion Channels (Ion Channel)IBA
01/2017 - 11/2016
2Paclitaxel (Taxol)FDA LinkGeneric
11/2016 - 06/2015
2ProstaglandinsIBA
01/2015 - 10/2012
2Cyclooxygenase InhibitorsIBA
03/2014 - 01/2013
1NF-kappa B (NF-kB)IBA
10/2022
1p38 Mitogen-Activated Protein KinasesIBA
10/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022
1Intergenic DNA (Junk DNA)IBA
01/2021
1Alanine Transaminase (SGPT)IBA
08/2019
1BilirubinIBA
08/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2019
1Prothrombin (Factor II)IBA
08/2019
1SuspensionsIBA
09/2018
1Formaldehyde (Formol)FDA Link
09/2018
1ParaffinIBA
09/2018
1LigandsIBA
01/2018
1EpitopesIBA
01/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1LeukotrienesIBA
01/2017
1Glycoproteins (Glycoprotein)IBA
01/2017
1ThromboxanesIBA
01/2017
1Collagen ReceptorsIBA
01/2017
1Prostaglandin H2 Thromboxane A2 ReceptorsIBA
01/2017
1CollagenIBA
01/2017
1Telmisartan (Micardis)FDA Link
11/2016
1Protein Isoforms (Isoforms)IBA
11/2016
1Cytostatic AgentsIBA
11/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1phospholipase C epsilonIBA
01/2016
1oxidized low density lipoproteinIBA
07/2015
1Caspase 3 (Caspase-3)IBA
07/2015
1Sphingosine-1-Phosphate ReceptorsIBA
06/2015
1FTY 720PIBA
06/2015
1Fingolimod Hydrochloride (FTY720)FDA Link
06/2015
1lipoxin A4IBA
01/2015
1Leukotriene B4IBA
01/2015
1OxazoloneIBA
01/2015
1Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2015
1AntibodiesIBA
07/2014
1Epoprostenol (Prostacyclin)FDA LinkGeneric
03/2014
1Meloxicam (Mobic)FDA LinkGeneric
03/2014
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2014
1Epoprostenol ReceptorsIBA
03/2014
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
01/2013
113-hydroxy-9,11-octadecadienoic acidIBA
01/2013
1Analgesics (Analgesic Drugs)IBA
01/2013
1Chemotactic FactorsIBA
10/2012
1SphingolipidsIBA
10/2012
1SphingosineIBA
10/2012

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2016 - 06/2015
1Therapeutics
11/2016